⚙AI-generated summary
by claude@2026-06, 2026-06-12
ⓘ
This paper describes a rare ovarian mixed carcinoma featuring mesonephric-like, clear cell, and endometrioid components arising from an endometriotic cyst, sharing identical KRAS and PIK3CA mutations.
One-sentence paraphrase of the abstract; not a substitute for reading it.
No clinical advice. How this works
⚙AI-generated deep summary
by claude@2026-06, 2026-06-12
· read from full text
ⓘ
This paper reports a case of mixed mesonephric-like adenocarcinoma, clear cell carcinoma, and endometrioid carcinoma arising from an endometriotic cyst, describing the tumor’s pathological composition. The study is based on clinical-pathologic observation rather than a cohort or experimental design, and it does not provide population-level outcomes. A key finding is that multiple distinct histologic carcinoma components can be present in association with an endometriotic cyst. This paper is centrally about endometriosis — it documents malignant transformation involving endometriotic cyst tissue leading to several ovarian carcinoma subtypes.
Read from the paper's body, not the abstract. Not a substitute for
reading the paper. No clinical advice.
How this works
Abstract
Mesonephric-like adenocarcinoma is a rare neoplasm of the uterine corpus and ovary. Unlike prototypical mesonephric adenocarcinoma of the uterine cervix, which is considered of Wolffian origin, recent evidence suggests that mesonephric-like adenocarcinoma is a Mullerian tumor associated with endometriosis. We report here on a 48-year-old woman with a mixed carcinoma of the ovary that consisted of mesonephric-like adenocarcinoma, clear cell carcinoma, and endometrioid carcinoma, arising from an endometriotic cyst. The mesonephric-like adenocarcinoma consisted of cuboidal cells with vesicular nuclei presenting with a tubular, ductal, papillary, and solid architecture forming nodules. Each component showed distinct immunophenotypes that were consistent with their morphology. The mesonephric-like adenocarcinoma showed diffuse positive staining for paired box 8 and GATA binding protein 3, and negative staining for estrogen and progesterone receptors. A p53 stain exhibited wild-type immunoreactivity. A complete loss of AT-rich interactive domain-containing protein 1A (ARID1A) expression was suggestive of an ARID1A mutation. Manual macrodissection and Sanger sequencing revealed identical KRAS and PIK3CA mutations in all three components. To the best of our knowledge, this is the first report of mesonephric-like adenocarcinoma combined with a clear cell carcinoma and endometrioid carcinoma, which supports the hypothesis that mesonephric-like adenocarcinoma is an endometriosis-associated neoplasm. The report also highlights a potential pitfall in diagnosing mesonephric-like adenocarcinoma combined with clear cell carcinoma.
Full text
2,136 characters
· extracted from
oa-doi-fallback
· 3 sections
· click to expand
Abstract
Get full access to this article
View all access and purchase options for this article.
References
Cite
Cite
Cite
Download to reference manager
If you have citation software installed, you can download citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
https://www.webofscience.com/api/gateway/wos/peer-review/10.1177/10668969231213390
Keywords
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in International Journal of Surgical Pathology.
View All Journal MetricsPublication usage*
Total views and downloads: 490
*Publication usage tracking started in December 2016
Publications citing this one
Receive email alerts when this publication is cited
Web of Science: 6 view articles Opens in new tab
Crossref: 6
- Mesonephric-like adenocarcinoma of the ovary: features of a rare and aggressive entity associated with endometriosis
- Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium
- Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics
- Ovarian Mesonephric-Like Adenocarcinoma Arising from an Endometriotic Cyst with an Identical KRAS Mutation in Both Components: A Case Report
- Primary Carcinomas of the Episiotomy Scar Site: A Systematic Literature Review
- Ovarian Mesonephric-like Adenocarcinoma: Its Prevalence in a Japanese High-Volume Cancer Center and a Literature Review on Therapeutic Targets
Figures and tables
Figures & Media
Tables
View Options
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.
My notes (saved in your browser only)
⚙Ask this paper
AI returns verbatim quotes from the full text
· source: oa-doi-fallbackⓘ
Answers must be backed by verbatim quotes from this paper's full text.
Hallucinated quotes are dropped automatically; if no verbatim passage
answers the question, we say so. How this works
We don't have any in-corpus citations linked to this paper yet.
This is a recent paper (2024) — citers
typically take a year or two to land, and the OpenAlex reference
graph may still be filling in.
Source provenance
europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
pubmed
last seen: 2026-06-11T06:18:13.256595+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine